Cargando…
Bone Marrow‐Derived Mesenchymal Stem Cells‐Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA‐Dependent Mechanisms
The loss of retinal ganglion cells (RGC) and their axons is one of the leading causes of blindness and includes traumatic (optic neuropathy) and degenerative (glaucoma) eye diseases. Although no clinical therapies are in use, mesenchymal stem cells (MSC) have demonstrated significant neuroprotective...
Autores principales: | Mead, Ben, Tomarev, Stanislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442835/ https://www.ncbi.nlm.nih.gov/pubmed/28198592 http://dx.doi.org/10.1002/sctm.16-0428 |
Ejemplares similares
-
The role of miRNA in retinal ganglion cell health and disease
por: Mead, Ben, et al.
Publicado: (2021) -
Retinal ganglion cell neuroprotection by growth factors and exosomes: lessons from mesenchymal stem cells
por: Mead, Ben, et al.
Publicado: (2018) -
miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage
por: Mead, Ben, et al.
Publicado: (2021) -
TNFα-Mediated Priming of Mesenchymal Stem Cells Enhances Their Neuroprotective Effect on Retinal Ganglion Cells
por: Mead, Ben, et al.
Publicado: (2020) -
Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma
por: Mead, Ben, et al.
Publicado: (2018)